BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS
29 results:

  • 1. Diagnostic value of methylated branched chain amino acid transaminase 1/ikaros family zinc finger 1 for colorectal cancer.
    Xu K; Yu AR; Pan SB; He J
    World J Gastroenterol; 2023 Sep; 29(36):5240-5253. PubMed ID: 37901447
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluation of a Multi-Gene Methylation Blood-Test for the Detection of colorectal cancer.
    Petit J; Carroll G; Williams H; Pockney P; Scott RJ
    Med Sci (Basel); 2023 Sep; 11(3):. PubMed ID: 37755164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.
    Brenne SS; Madsen PH; Pedersen IS; Hveem K; Skorpen F; Krarup HB; Giskeødegård GF; Laugsand EA
    Br J Cancer; 2023 Sep; 129(5):861-868. PubMed ID: 37438612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
    You W; Ouyang J; Cai Z; Chen Y; Wu X
    Front Immunol; 2022; 13():827506. PubMed ID: 35874675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Detection of methylated BCAT1 and ikzf1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
    Pedersen SK; Symonds EL; Roy AC; Cornthwaite KJ; LaPointe LC; Young GP
    Cancer Med; 2023 Jan; 12(2):1319-1329. PubMed ID: 35822405
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and ikzf1.
    Pedersen SK; Musher BL; LaPointe LC; Tuck MK; Symonds EL; Loayza N; Young GP
    Cancer; 2022 May; 128(10):1921-1928. PubMed ID: 35290664
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.
    Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ
    BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Detection of hypermethylated BCAT1 and ikzf1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
    Winter JM; Sheehan-Hennessy L; Yao B; Pedersen SK; Wassie MM; Eaton M; Chong M; Young GP; Symonds EL
    Cancer Biomark; 2022; 34(3):493-503. PubMed ID: 35253733
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/ikzf1.
    Symonds EL; Pedersen SK; Yeo B; Al Naji H; Byrne SE; Roy A; Young GP
    Mol Oncol; 2022 May; 16(10):2031-2041. PubMed ID: 35000264
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of newly identified ikaros family zinc finger 1 loci in colorectal cancer.
    Sharma B; Shah R; Jamwal RS; Verma S; Bhat A; Bhat GR; Bakshi D; Singh S; Angurana S; Bhat A; Vaishnavi S; Kumar R
    J Cancer Res Ther; 2021; 17(1):46-50. PubMed ID: 33723131
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Variables Associated with Detection of Methylated
    Saluja H; Young GP; Kholmurodova F; Symonds EL
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):774-781. PubMed ID: 33500319
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, ikzf1 and BCAT1 for blood-based detection of colorectal cancer.
    Young GP; Symonds EL; Nielsen HJ; Ferm L; Christensen IJ; Dekker E; van der Vlugt M; Mallant-Hent RC; Boulter N; Yu B; Chan M; Tevz G; LaPointe LC; Pedersen SK
    Clin Epigenetics; 2021 Jan; 13(1):14. PubMed ID: 33478584
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of Circulating Tumor DNA for Methylated
    Musher BL; Melson JE; Amato G; Chan D; Hill M; Khan I; Kochuparambil ST; Lyons SE; Orsini J; Pedersen SK; Robb B; Saltzman J; Silinsky J; Gaur S; Tuck MK; LaPointe LC; Young GP
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2702-2709. PubMed ID: 32958500
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.
    Symonds EL; Pedersen SK; Murray D; Byrne SE; Roy A; Karapetis C; Hollington P; Rabbitt P; Jones FS; LaPointe L; Segelov E; Young GP
    Cancer; 2020 Apr; 126(7):1460-1469. PubMed ID: 31909823
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases.
    Sun J; Wang C; Zhang Y; Xu L; Fang W; Zhu Y; Zheng Y; Chen X; Xie X; Hu X; Hu W; Zheng J; Li P; Yu J; Mei Z; Cai X; Wang B; Hu Z; Shu Y; Shen H; Gu Y
    Nat Commun; 2019 Jul; 10(1):3190. PubMed ID: 31320627
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Detection of colorectal cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing.
    Li J; Zhou X; Liu X; Ren J; Wang J; Wang W; Zheng Y; Shi X; Sun T; Li Z; Kang A; Tang F; Wen L; Fu W
    Clin Chem; 2019 Jul; 65(7):916-926. PubMed ID: 31010820
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.
    Cock C; Anwar S; Byrne SE; Meng R; Pedersen S; Fraser RJL; Young GP; Symonds EL
    Dig Dis Sci; 2019 Sep; 64(9):2555-2562. PubMed ID: 30835026
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.
    Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.
    Symonds EL; Pedersen SK; Murray DH; Jedi M; Byrne SE; Rabbitt P; Baker RT; Bastin D; Young GP
    Clin Epigenetics; 2018; 10():63. PubMed ID: 29796114
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.